Medacta Group Sa Stock Performance
| MEDGF Stock | USD 83.91 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Medacta Group are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Medacta Group SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Medacta Group is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 48.1 M | |
| Total Cashflows From Investing Activities | -52 M |
Medacta |
Medacta Group Relative Risk vs. Return Landscape
If you would invest 8,391 in Medacta Group SA on November 1, 2025 and sell it today you would earn a total of 0.00 from holding Medacta Group SA or generate 0.0% return on investment over 90 days. Medacta Group SA is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Medacta, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Medacta Group Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Medacta Group for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Medacta Group SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Medacta Group SA generated a negative expected return over the last 90 days | |
| About 70.0% of the company outstanding shares are owned by corporate insiders |
Medacta Group Fundamentals Growth
Medacta Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Medacta Group, and Medacta Group fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medacta Pink Sheet performance.
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0752 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 2.11 B | |||
| Shares Outstanding | 19.98 M | |||
| Price To Earning | 37.53 X | |||
| Price To Book | 6.32 X | |||
| Price To Sales | 5.60 X | |||
| Revenue | 363.13 M | |||
| EBITDA | 99.33 M | |||
| Cash And Equivalents | 22.24 M | |||
| Cash Per Share | 1.11 X | |||
| Total Debt | 47.7 M | |||
| Debt To Equity | 0.67 % | |||
| Book Value Per Share | 12.62 X | |||
| Cash Flow From Operations | 54.06 M | |||
| Earnings Per Share | 2.52 X | |||
| Total Asset | 489.27 M | |||
About Medacta Group Performance
By analyzing Medacta Group's fundamental ratios, stakeholders can gain valuable insights into Medacta Group's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Medacta Group has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Medacta Group has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland. Medacta Group operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 1421 people.Things to note about Medacta Group SA performance evaluation
Checking the ongoing alerts about Medacta Group for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Medacta Group SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medacta Group SA generated a negative expected return over the last 90 days | |
| About 70.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Medacta Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medacta Group's stock is overvalued or undervalued compared to its peers.
- Examining Medacta Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medacta Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medacta Group's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medacta Group's pink sheet. These opinions can provide insight into Medacta Group's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Medacta Pink Sheet analysis
When running Medacta Group's price analysis, check to measure Medacta Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medacta Group is operating at the current time. Most of Medacta Group's value examination focuses on studying past and present price action to predict the probability of Medacta Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medacta Group's price. Additionally, you may evaluate how the addition of Medacta Group to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |